8-K ·Filed Jun 15, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
This is a routine FD disclosure with no new information. Monitor the company's website for the actual presentation content, but no immediate trading action is warranted.
Final — all horizons settled through T+60d
CRVO ▼ -45.13% at T+60d
NEUTRAL call -45.13% · α vs SPY -46.13% · entry $4.52 → $2.48
T+1d
-15.71%
call -15.71% · α -14.46%
$3.81
settled 4mo ago
T+5d
-17.70%
call -17.70% · α -15.47%
$3.72
settled 4mo ago
T+20d
-31.86%
call -31.86% · α -32.06%
$3.08
settled 3mo ago
T+60d
-45.13%
call -45.13% · α -46.13%
$2.48
settled 7w ago
Price Chart
Loading chart...
Executive Summary
CervoMed Inc. filed an 8-K under Item 7.01 to disclose that an investor presentation has been made available on its website. The filing contains no new financial data, guidance, or material corporate events — it is a routine Regulation FD disclosure of existing materials.
Key Facts
- Filing is a Regulation FD disclosure of an investor presentation posted on the company website.
- No preliminary financial results, guidance updates, or material agreements were disclosed.
- The presentation is intended for use at investor conferences and meetings.
- No exhibit (EX-99.1) was attached — the filing references only the website content.
Financial Impact
No financial figures or material changes disclosed.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-020672 |
| Document: 0001437749-26-020672-index-headers.html | 0001437749-26-020672 |
| Document: 0001437749-26-020672-index.html | 0001437749-26-020672 |
| Document: 0001437749-26-020672.txt | 0001437749-26-020672 |
23 reports for CRVO
86% Hit rate @ T+1 Went positive at some point 12 of 14 best @ T+60▲ +40.68%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $2.25 $2.24 | ▼ −0.44% | ▲ +0.66% | $2.31 (+2.67%) |
Oct 13, 2026 13d ago | 8-K | $2.27 $2.29 | ▲ +0.88% | ▲ +1.96% | $2.31 (+1.76%) |
Oct 9, 2026 17d ago | 8-K | $2.51 $2.27 | ▼ −9.56% | ▼ −9.55% | $2.31 (−7.97%) |
Sep 10, 2026 6w ago | Press Release | $2.48 $2.57 | ▲ +3.63% | ▲ +2.78% | $2.31 (−6.85%) |
Aug 10, 2026 11w ago | 8-K | $3.09 $3.07 | ▼ −0.65% | ▼ −0.90% | $2.31 (−25.24%) |
Aug 4, 2026 11w ago | 8-K | $2.80 $2.81 | ▲ +0.36% | ▲ +0.56% | $2.31 (−17.50%) |
Aug 4, 2026 11w ago | Press Release | $2.80 $2.81 | ▲ +0.36% | ▲ +0.56% | $2.31 (−17.50%) |
Jul 13, 2026 15w ago | EFFECT | $3.31 $3.08 | ▲ +6.95% | ▲ +7.30% | $2.31 (+30.21%) |
Jul 6, 2026 16w ago | S-3 | $3.42 $3.41 | ▲ +0.29% | ▼ −0.02% | $2.31 (+32.46%) |
Jun 22, 2026 18w ago | 8-K | $3.72 $3.26 | ▲ +12.37% | ▲ +12.32% | $2.31 (+37.90%) |
Showing 10 of 23
US Market Status
Market Closed — Opens Wed (12h 38m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers